SciSparc (SPRC) Goodwill & Intangibles (2022 - 2025)
SciSparc (SPRC) posted Goodwill & Intangibles of $1.2 million for Q4 2025, down 15.4% sequentially from $1.4 million in Q2 2025, and down 20.89% YoY from $1.5 million in Q4 2024.
SciSparc (SPRC) Goodwill & Intangibles (2022 - 2025) Analysis & Trends
SciSparc has reported Goodwill & Intangibles for 4 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Goodwill & Intangibles fell 20.89% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 20.89% YoY) and the FY2025 annual result came in at $1.2 million, down 20.89% from the prior year.
- Goodwill & Intangibles slipped to $1.2 million in Q4 2025 per SPRC's latest filing, from $1.4 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $4.7 million in Q4 2022 and troughed at $1.2 million in Q4 2025.
- A 4-year average of $2.8 million and a median of $3.0 million in 2024 frame the typical range for Goodwill & Intangibles.
- The widest YoY moves for Goodwill & Intangibles: up 20.89% in 2025, down 53.99% in 2025.
- Over 4 years, Goodwill & Intangibles stood at $4.7 million in 2022, then tumbled by 32.39% to $3.2 million in 2023, then sank by 53.62% to $1.5 million in 2024, then retreated by 20.89% to $1.2 million in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $1.2 million, $1.4 million, and $1.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Jun 30, 2024 | 3.01 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Jun 30, 2023 | 4.47 Mn |
| Dec 31, 2022 | 4.72 Mn |